Outbreaks Strain Supplies and Wallets (Image Credits: Foodbusinessnews.net)
The US poultry industry contends with the enduring outbreak of highly pathogenic avian influenza (HPAI), which has strained egg production and elevated consumer prices without an approved commercial vaccine in sight.[1][2]
Outbreaks Strain Supplies and Wallets
Highly pathogenic avian influenza first struck US flocks in February 2022 and persists as a major threat to poultry operations nationwide. The virus has forced widespread culling, disrupting the nation’s egg supply and contributing to record-high prices earlier in 2025. Consumers felt the pinch through higher costs for eggs and poultry products, prompting federal responses under the previous administration.
Current control measures rely on rapid detection and depopulation, as vaccination faces hurdles like international trade restrictions and biosecurity concerns. Experts note that traditional vaccines demand labor-intensive administration, heightening contamination risks in large-scale operations.[1]
Federal Funding Ignites Innovation Drive
The US Department of Agriculture’s Animal and Plant Health Inspection Service launched the HPAI Poultry Innovation Grand Challenge, allocating $100 million to advance prevention, therapeutics, and vaccine development. This initiative supports collaborations among universities, vaccine makers, and industry groups to tackle transmission and bolster biosecurity.[2]
Chelsey Shivley, a veterinarian with APHIS and assistant director of the challenge, emphasized the need for better tools after years of recurring outbreaks. “This virus keeps popping its head back up,” she stated during a recent panel at the Agricultural Outlook Forum. “We’re investing now to figure out if we can add these tools. But at this time, nothing will change.”[1]
Mealworms Emerge as Vaccine Delivery Pioneers
Kansas State University leads a novel project engineering mealworms to deliver HPAI vaccines orally through poultry feed. This “bug-to-bird” method uses CRISPR to produce antigens in the insects, which birds consume naturally. Partnering with North Carolina State University and the Insect Farming Initiative, researchers aim to sidestep the pitfalls of injectable vaccines.[1][3]
Laura Miller, associate professor of veterinary virology at Kansas State, highlighted the advantages. “Our oral, insect-based vaccine can be delivered as a feed supplement, allowing a producer to protect thousands of birds quickly without the stress of manual handling,” she explained. “Mealworms offer significant nutritional benefits while serving as efficient biological factories for vaccine antigens.”[1]
- Shelf-stable transport without refrigeration
- Scalable for millions of birds via standard feeding
- Lower biosecurity risks, no individual handling
- Rapid adaptation to evolving virus strains
- Reduced labor and stress-related losses
| Approach | Traditional Vaccines | Mealworm Method |
|---|---|---|
| Delivery | Individual injections | Feed supplement |
| Handling Needs | Certified crews, weeks-long process | None required |
| Stability | Fragile, temp-controlled | Shelf-stable |
Trials Abroad Offer Lessons for US Efforts
The United Kingdom initiated field trials of HPAI vaccines in turkeys on March 5, 2026, marking a step toward broader use. Officials hope the 24-week study will demonstrate efficacy and integration into control strategies, protecting biosecurity and food supplies.[4]
Biosecurity Minister Baroness Hayman noted the trials’ potential: “We are hopeful vaccines can be used in the UK as an additional tool to control bird flu.” Such international data could inform US strategies as domestic research progresses.
- No commercial HPAI vaccines approved for US poultry yet, but $100 million in funding supports promising projects.
- Mealworm-based delivery addresses key barriers like labor and stability.
- Ongoing outbreaks underscore urgency for faster detection and prevention tools.
As HPAI continues to challenge flocks and food chains, these research strides point toward a more resilient future for poultry production. Innovations like insect-delivered vaccines could transform defenses against this persistent foe. What steps should the industry prioritize next? Share your thoughts in the comments.
